Patent US4952483A successfully refreshed from Google Patents.
US4952483A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Direct positive silver halide photosensitive material and method for forming direct positive image
Assignee: Fujifilm Holdings Corp
•
Filing: 1988-03-21
•
Granted: 1990-08-28
•
Expires: 2008-03-21
Abstract
Abstract The present invention relates to a direct positive silver halide photosensitive material and a method for forming a direct positive image. By the use of a novel nucleating agent having a specific structural formula, the present invention provides a direct positive silver halide photosensitive material with an increased Dmax value and a decreased Dmin value, as compared with the use of the conventional nucleating agents, even if a small amount of the novel nucleating agent is used, and does not substantially reduce the Dmax value, even if the photosensitive material is kept in a high-humidity state for a long time before exposure.
Inventors
- 👤 Noriyuki Inoue
- 👤 Morio Yagihara
- 👤 Hisashi Okada
- 👤 Tetunoti Matushita
- 👤 Satoshi Nagaoka
- 👤 Tetsuro Kojima
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 19:45
CPC Classifications
G; G03; G03C; G03C1/00; G03C1/005; G03C1/485; G03C1/48538; G03C1/48546; G03C1/48561; G03C1/06; G03C1/061; G03C1/08; G03C1/10; G03C2001/108
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
627 words
A method for forming a direct positive image comprising imagewise exposing a photosensitive material comprising at least one layer of a previously unfogged internal latent image-type silver halide emulsion on a support and then conducting a surface color developing at pH 9.8 to 11.5 in the presence of a p-phenylenediamine compound and a nucleating agent, said nucleating agent being expressed by the following formula (I): ##STR26## wherein A 1 and A 2 both denote hydrogen atoms or one of A 1 and A 2 denotes a hydrogen atom and the other denotes a sulfinic acid residue or an acyl group; R 1 denotes an aliphatic, aromatic or heterocyclic group; R 2 denotes a hydrogen atom or an alkyl, aryl, alkoxyl, aryloxy or amino group, at least one of R 1 and R 2 having at least one substituent which has a pKa of 6 or more and can dissociate into an anion; and G denotes a carbonyl, sulfonyl, sulfoxy, phosphoryl or iminomethylene group, and wherein said development is performed in the presence of at least one of a nitrogen-containing heterocyclic compound which serves as a nucleation accelerator for accelerating the function of said nucleation agent, and wherein said nucleation accelerator is expressed by the formulae (II), (III), (IV), (V), (VI), (VII) or (VIII): ##STR27## wherein Q denotes an atomic group necessary for forming a 5- or 6-membered heterocyclic ring which may be condensed with an aromatic carbon ring or an aromatic heterocyclic ring, M denotes a hydrogen or alkali metal atom, an ammonium group, or a group which can cleave under alkali conditions: ##STR28## wherein M denotes the same as that of Formula (Il); X denotes an oxygen, sulfur, or selenium atom, Y denotes --S--, ##STR29## wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 each denotes a hydrogen atom, a substituted or unsubstituted alkyl, aryl, alkenyl or aralkyl group; R denotes a straight or branched chain alkylene, alkenylene or aralkylene group, or an arylene group; Z denotes a hydrogen or halogen atom, a nitro or cyano group, or a substituted or unsubstituted amino, quaternary ammonium, alkoxyl, aryloxy, alkylthio, arylthio, heterocyclic oxy, heterocyclic thio, sulfonyl, carbamoyl, sulfamoyl, carbonamido, sulfonamido, acyloxy, sulfonyloxy, ureido, thioureido, acyl, heterocyclic, oxycarbonyl, oxysulfonyl, oxycarbonylamino or mercapto group; and n denotes 0 or 1: ##STR30## wherein R' denotes a hydrogen or halogen atom, a nitro, mercapto, or unsubstituted amino group, or (--Y) n --R--Z; and R" denotes a hydrogen atom, an unsubstituted amino group or --Y' m R--Z wherein Y' denotes ##STR31## denotes 0 or 1; M, R, Z, Y, n, R 1 R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 each denoting the same as that of Formula III: ##STR32## wherein Q' denotes a triazaindene, tetraazaindene or pentazaindene; and M denotes the same as that of Formula (II): ##STR33## wherein T denotes a divalent connecting group consisting of an atom selected from the group consisting of carbon, nitrogen, oxygen and sulfur; U denotes an organic group containing at least one of a thioether, amino, ammonium, ether or heterocyclic group; p denotes 0 or 1; q denotes 1 or 2; and Q and M denote the same as those of Formula (II): ##STR34## wherein Q" denotes an atomic group necessary for forming a 5- or 6- member heterocyclic ring which can produce imino silver; and M denotes the same as that of Formula (II): ##STR35## wherein Q"' denotes an atomic group necessary for forming a 5- or 6-member heterocyclic ring which can produce imino silver; M denotes the same as that of Formula (II); and --(T) p U q denotes the same as that of Formula (VI).
Claim 2
Independent Claim
627 words
A method for forming a direct positive image comprising imagewise exposing a photosensitive material comprising at least one layer of a previously unfogged internal latent image-type silver halide emulsion on a support and then conducting a surface color developing at pH 9.8 to 11.5 in the presence of a p-phenylenediamine compound and a nucleating agent, said nucleating agent being expressed by the following formula (I): ##STR26## wherein A 1 and A 2 both denote hydrogen atoms or one of A 1 and A 2 denotes a hydrogen atom and the other denotes a sulfinic acid residue or an acyl group; R 1 denotes an aliphatic, aromatic or heterocyclic group; R 2 denotes a hydrogen atom or an alkyl, aryl, alkoxyl, aryloxy or amino group, at least one of R 1 and R 2 having at least one substituent which has a pKa of 6 or more and can dissociate into an anion; and G denotes a carbonyl, sulfonyl, sulfoxy, phosphoryl or iminomethylene group, and wherein said development is performed in the presence of at least one of a nitrogen-containing heterocyclic compound which serves as a nucleation accelerator for accelerating the function of said nucleation agent, and wherein said nucleation accelerator is expressed by the formulae (II), (III), (IV), (V), (VI), (VII) or (VIII): ##STR27## wherein Q denotes an atomic group necessary for forming a 5- or 6-membered heterocyclic ring which may be condensed with an aromatic carbon ring or an aromatic heterocyclic ring, M denotes a hydrogen or alkali metal atom, an ammonium group, or a group which can cleave under alkali conditions: ##STR28## wherein M denotes the same as that of Formula (Il); X denotes an oxygen, sulfur, or selenium atom, Y denotes --S--, ##STR29## wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 each denotes a hydrogen atom, a substituted or unsubstituted alkyl, aryl, alkenyl or aralkyl group; R denotes a straight or branched chain alkylene, alkenylene or aralkylene group, or an arylene group; Z denotes a hydrogen or halogen atom, a nitro or cyano group, or a substituted or unsubstituted amino, quaternary ammonium, alkoxyl, aryloxy, alkylthio, arylthio, heterocyclic oxy, heterocyclic thio, sulfonyl, carbamoyl, sulfamoyl, carbonamido, sulfonamido, acyloxy, sulfonyloxy, ureido, thioureido, acyl, heterocyclic, oxycarbonyl, oxysulfonyl, oxycarbonylamino or mercapto group; and n denotes 0 or 1: ##STR30## wherein R' denotes a hydrogen or halogen atom, a nitro, mercapto, or unsubstituted amino group, or (--Y) n --R--Z; and R" denotes a hydrogen atom, an unsubstituted amino group or --Y' m R--Z wherein Y' denotes ##STR31## denotes 0 or 1; M, R, Z, Y, n, R 1 R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 each denoting the same as that of Formula III: ##STR32## wherein Q' denotes a triazaindene, tetraazaindene or pentazaindene; and M denotes the same as that of Formula (II): ##STR33## wherein T denotes a divalent connecting group consisting of an atom selected from the group consisting of carbon, nitrogen, oxygen and sulfur; U denotes an organic group containing at least one of a thioether, amino, ammonium, ether or heterocyclic group; p denotes 0 or 1; q denotes 1 or 2; and Q and M denote the same as those of Formula (II): ##STR34## wherein Q" denotes an atomic group necessary for forming a 5- or 6- member heterocyclic ring which can produce imino silver; and M denotes the same as that of Formula (II): ##STR35## wherein Q"' denotes an atomic group necessary for forming a 5- or 6-member heterocyclic ring which can produce imino silver; M denotes the same as that of Formula (II); and --(T) p U q denotes the same as that of Formula (VI).
Claim 3
Dependent Claim
34 words
The method of claim 1, wherein said photosensitive material contains a color image-forming coupler, said color image-forming coupler being nondispersible and producing or releasing a dye by the oxidative coupling with said developing agent.
Claim 4
Dependent Claim
31 words
The method of claim 1, wherein said nucleating agent is used in a processing solution in an amount of 10 -5 to 10 -1 mole per liter of said processing solution.
Claim 5
Dependent Claim
31 words
The method of claim 3, wherein said nucleating agent is used in said processing solution in an amount of 10 -4 to 10 -2 mole per liter of said processing solution.
Claim 6
Dependent Claim
26 words
The method of claim 1, wherein said nucleation accelerator is used in an amount of 10 -6 to 10 -2 mole per mole of silver halide.
Claim 7
Dependent Claim
26 words
The method of claim 5, wherein said nucleation accelerator is used in an amount of 10 -5 to 10 -2 mole per mole of silver halide.
References Cited (Backward Citations)
US3637387A
Cited
GB2012443A
Cited
GB2038012A
Cited
US4245037A
Cited
GB2052880A
Cited
US4278748A
Cited
US4323643A
Cited
GB2107074A
Cited
US4481285A
Cited
US4550070A
Cited
EP0130856A2
Cited
US4582779A
Cited
EP0143436A2
Cited
EP0154293A2
Cited
US4717648A
Cited
US4749644A
Cited
JPS6315248A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1993-08-27 | 1994-02-26 | 1994-08-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1997-08-27 | 1998-02-26 | 1998-08-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2001-08-27 | 2002-02-26 | 2002-08-28 | $7700.00 | Window Closed / Lapsed |